Vanda Pharmaceuticals Inc.

NasdaqGM:VNDA Stock Report

Mkt Cap: US$434.0m

Vanda Pharmaceuticals Past Performance

How has Vanda Pharmaceuticals performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


11.4%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: VNDA has high quality earnings.

Growing Profit Margin: VNDA's current net profit margins (2.5%) are lower than last year (12.8%).


Past Earnings Growth Analysis

Earnings Trend: VNDA has become profitable over the past 5 years, growing earnings by 11.4% per year.

Accelerating Growth: VNDA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: VNDA had negative earnings growth (-81.1%) over the past year, making it difficult to compare to the Biotechs industry average (53%).


Return on Equity

High ROE: VNDA's Return on Equity (1.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies